4-Methyl-4-phenylpiperidine → HCID 178469970, 화합물

HRID 1026930노트

반응식

HRID 1026930 반응식
[CH2:1]([O:3][C:4]([C:6]1[CH:7]=[N:8][N:9]2[C:14]([OH:15])=[C:13]([C:16]([OH:18])=O)[CH:12]=[N:11][C:10]=12)=[O:5])[CH3:2].[CH3:19][C:20]1([C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]1>>[CH2:1]([O:3][C:4]([C:6]1[CH:7]=[N:8][N:9]2[C:14]([OH:15])=[C:13]([C:16]([N:23]3[CH2:24][CH2:25][C:20]([CH3:19])([C:26]4[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=4)[CH2:21][CH2:22]3)=[O:18])[CH:12]=[N:11][C:10]=12)=[O:5])[CH3:2]

참가 물질

3

반응물 2

HCID 30195114-Methyl-4-phenylpiperidineHCID 178469973HCID 178469973, 화합물

생성물 1

HCID 178469970HCID 178469970, 화합물수율 69%

실험 절차

In the same manner as in Example 1, step 2 and using 3-ethoxycarbonyl-7-hydroxypyrazolo[1,5-a]pyrimidine-6-carboxylic acid (583 mg, 2.32 mmol) obtained in Example 19, step 2 and 4-methyl-4-phenylpiperidine (Journal of Medicinal Chemistry, vol. 41, page 5320, 590 mg, 2.79 mmol), the title compound (650 mg, 69%) was obtained.

출처 및 근거

ORD 기록
ord-f5d443cf4e3341da919f42e2b2b7d783
출처 데이터셋
uspto-grants-2014_05
특허 번호
US08729264B2

반응 노트

불러오는 중…